Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.7526
-0.0814 ( -9.76% ) 497.6K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.7526
Previous close
$0.8340
Volume
497.6K
Market cap
$128.82M
Day range
$0.7520 - $0.8720
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 74 | May 15, 2024 |
| 8-k | 8K-related | 13 | Apr 30, 2024 |
| 8-k | 8K-related | 15 | Apr 25, 2024 |
| 8-k/a | 8K-related | 16 | Apr 24, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 13, 2024 |
| 3 | Insider transactions | 1 | Mar 13, 2024 |
| 8-k | 8K-related | 15 | Mar 13, 2024 |
| 8-k | 8K-related | 14 | Mar 07, 2024 |
| 8-k | 8K-related | 14 | Mar 05, 2024 |